Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-04-09-Speech-3-166"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20080409.22.3-166"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"First of all, I would like to take this opportunity, as the Chairman of the Committee on the Environment, Public Health and Food Safety, to congratulate the Commissioner, who was nominated and appointed to the Commission today. Although serious reasons prevented me from listening to her presentation in person, I must say that she made an excellent impression on the members of my committee and was unanimously welcomed in her new capacity.
Regarding the oral question, I would like to begin by explaining what made us tackle this issue and ask individual states to pay more attention to this serious diagnosis. You probably know, from the emphasis in the report and in the question, that cancer cases in Europe are on the increase. There are a number of reasons for this: as we know, the population is ageing and more and more people are exposed to carcinogens. According to the trade unions, at least 8% of annual cancer deaths are directly caused by exposure to carcinogens in the workplace. We have to bear in mind that one in three Europeans is diagnosed with cancer during their lifetime and one in four Europeans dies from the disease.
Another important matter is the significant differences in cancer treatment success rates between the old and new Member States. This imbalance is surely also food for thought. What can we do in this area and what can we recommend to the European Community? A structure such as the EU undoubtedly has the capacity and power to coordinate individual national policies. By adopting national cancer control programmes we can reduce cancer mortality by as much as 30%. We know that only 3% of the total budget in developed countries is spent on cancer prevention, compared with 97% on treatment.
I would also like to take this opportunity to make an appeal on behalf of patients, who become the focus of our treatment and should become the focus of our care: they should have better access to new scientific knowledge and new information. The European Union should push ahead with a single register and, as far as possible, common education. Paradoxically, the European Union has not yet introduced in all its Member States as undeniably important a topic as oncology. Although oncology is an interdisciplinary subject, its recognition as a subject in its own right is a necessary condition if we want to successfully fight this disease.
Since I would like to allow my colleague from the PPE-DE Group, Professor Trakatellis, to use some of my speaking time, I will now conclude my introduction."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples